A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Cumulative Irritation Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 23 Jun 2017
At a glance
- Drugs Tazarotene (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- 19 Apr 2012 Actual initiation date changed from Apr 2010 to Mar 2010 as reported by ClinicalTrials.gov.
- 06 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2010 New trial record